Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma Meeting Abstract


Authors: Sternschuss, M.; Whiting, K.; Arbuiso, A.; Gupta, A.; Bent, E. H.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; Beylergil, V.; Funt, S. A.; Bajorin, D. F.; Iyer, G.; Ostrovnaya, I.; Aggen, D. H.; Rosenberg, J. E.
Abstract Title: Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma
Meeting Title: 2025 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 43
Issue: 16 Suppl.
Meeting Dates: 2025 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2025-06-01
Start Page: 4573
DOI: 10.1200/JCO.2025.43.16_suppl.4573
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 4573 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    660 Bajorin
  2. Gopakumar Vasudeva Iyer
    348 Iyer
  3. Oguz Akin
    269 Akin
  4. Ashley Regazzi
    92 Regazzi
  5. Jonathan Eric Rosenberg
    517 Rosenberg
  6. Samuel Aaron Funt
    139 Funt
  7. Aditi Gupta
    21 Gupta
  8. David Henry Aggen
    59 Aggen
  9. Karissa A. Whiting
    49 Whiting
  10. Firas Salem Ahmed
    5 Ahmed
  11. Eric Huttenlocher Bent
    4 Bent
  12. Stanley W. Liang
    3 Liang